Cidara Therapeutics Announces Late-Breaking Presentation on CD388 at 10?? ESWI Influenza Conference 2025 Biotech Investing
Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results Pharmaceutical Investing
argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025 Biotech Investing
Dover, Delaware -- Expert Systems Inc., a leading life sciences accelerator, Supports Traws Pharma Phase 2 Clinical Studies of Ratutrelvir -- a Novel Ritonavir-Free Antiviral for COVID-19. Pharmaceutical Investing
Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time Life Science Investing
KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025 Medical Device Investing
Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025 Medical Device Investing
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025 Biotech Investing
I-Mab To Present Positive Updated Givastomig Monotherapy Data at 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference on October 23, 2025 Life Science Investing
